The need for a global perspective on heart valve disease epidemiology: The SHVD working group on epidemiology of heart valve disease founding statement

Journal of Heart Valve Disease

Volumn 17, Issue 1, 2008, Pages 135-139

  Takkenberg, Johanna J M ^a   Rajamannan, Nalini M ^b   Rosenhek, Raphael ^c   Kumar, Arkalgud S ^d   Carapetis, Jonathan R ^e   Yacoub, Magdi H ^f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NORTHWESTERN UNIVERSITY   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^e MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH; HUMAN; MEDICAL SOCIETY; MORBIDITY; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; REVIEW; VALVULAR HEART DISEASE;

HEART VALVE DISEASES; HUMANS; MORBIDITY; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; WORLD HEALTH;

EID: 43749103358     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Yacoub MH, Takkenberg JJ. Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med. Feb 2005;2(2):60-61
2. Carapetis JR, Steer AC, Mulholland EK, et al. The global burden of group A streptococcal diseases. Lancet Infect Dis. Nov 2005;5(11):685-694
3. Carapetis JR, Currie BJ. Mortality due to acute rheumatic fever and rheumatic heart disease in the Northern Territory: a preventable cause of death in aboriginal people. Aust N Z J Public Health. Apr 1999;23(2):159-163
4. Grover A, Dhawan A, Iyengar SD, et al. Epidemiology of rheumatic fever and rheumatic heart disease in a rural community in northern India. Bull World Health Organ. 1993;71(1):59-66
5. Padmavati S. Present status of rheumatic fever and rheumatic heart disease in India. Indian Heart J. Jul-Aug 1995;47(4):395-398
6. Patel DC, Patel NI, Patel JD, et al. Rheumatic fever and rheumatic heart disease in school children of Anand. J. Assoc Physicians India. Dec 1986;34(12):837-839
7. Grover A, Vijayvergiya R, Thingam ST. Burden of rheumatic and congenital heart disease in India: lowest estimate based on the 2001 census. Indian Heart J. Jan-Feb 2002;54(1):104-107
8. Michaud C, rejo-Gutierrez J, Cruz C, et al. Rheumatic heart disease. In: DT J, ed. Disease control priorities in developing countries: a summary. Washington, D.C: World Bank; 1993:221-232
9. Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardio-graphic screening. N Engl J Med. Aug 2 2007;357(5):470-476
10. Carapetis JR. Rheumatic heart disease in developing countries. N Engl J Med. Aug 2 2007;357(5):439-441
11. Rheumatic fever and rheumatic heart disease. World Health Organ Tech Rep Ser. 2004;923:1-122, back cover
12. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet. Jul 9-15 2005;366(9480):155-168
13. McDonald M, Brown A, Noonan S, et al. Preventing recurrent rheumatic fever: the role of register based programmes. Heart. Sep 2005;91(9):1131-1133
14. Mocumbi AO, Yacoub S, Yacoub MH. Neglected tropical cardiomyopathies. Part II: Endomyocardial fibrosis. Heart, in press
15. Rajamannan NM, Bonow RO, Rahimtoola SH. Calcific aortic stenosis: an update. Nat Clin Pract Cardiovasc Med. May 2007;4(5):254-262
16. Lindroos M, Kupari M, Heikkila J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. Apr 1993;21(5):1220-1225
17. Roberts WC, Ko JM. Frequency by decades of uni-cuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. Feb 22 2005;111(7):920-925
18. Galante A, Pietroiusti A, Vellini M, et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J. Am Coll Cardiol. Oct 2001;38(4):1078-1082
19. Palta S, Pai AM, Gill KS, et al. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation. May 30 2000;101(21):2497-2502
20. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. Mar 11997;29(3):630-634
21. Drolet MC, Arsenault M, Couet J. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol. Apr 2 2003;41(7):1211-1217
22. Rajamannan NM, Edwards WD, Spelsberg TC. Hypercholesterolemic aortic-valve disease. N Engl J Med. Aug 14 2003;349(7):717-718
23. Rajamannan NM, Sangiorgi G, Springett M, et al. Experimental hypercholesterolemia induces apop-tosis in the aortic valve. J. Heart Valve Dis. May 2001;10(3):371-374
24. Ross J, Jr., Braunwald E. Aortic stenosis. Circulation. Jul 1968;38(1 Suppl):61-67
25. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J. Apr 1988;9 Suppl E:57-64
26. Pellikka PA, Nishimura RA, Bailey KR, et al. The natural history of adults with asymptomatic, hemo-dynamically significant aortic stenosis. J Am Coll Cardiol. Apr 1990;15(5):1012-1017
27. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. Aug 1 2006;48(3):el-148
28. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. Jan 2007;28(2):230-268
29. Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. Jun 2007;28(11):1358-1365
30. Rosenhek R, Rader F, Klaar U, et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation. May 9 2006;113(18):2238-2244
31. Marcus RH, Sareli P, Pocock WA, et al. The spectrum of severe rheumatic mitral valve disease in a developing country. Correlations among clinical presentation, surgical pathologic findings, and hemodynamic sequelae. Ann Intern Med. Feb 1 1994;120(3):177-183
32. Grunkemeier GL, Jin R, Eijkemans MJ, et al. Actual and actuarial probabilities of competing risks: apples and lemons. Ann Thorac Surg. May 2007;83(5):1586-1592